Lonza Enters into Biopharmaceutical Manufacturing Agreement with Genentech
Lonza to acquire mid-scale biomanufacturing facility and to build a second large-scale biomanufacturing facility in Singapore
13-Nov-2006 -
Lonza Group announced an agreement with Genentech, Inc. whereby Lonza will acquire Genentech's mid-scale mammalian biopharmaceutical production plant based in Porriño, Spain for $150 million. This facility is FDA-licensed and one of three Genentech plants that are currently licensed to produce ...
Genentech
Lonza
Singapore
+2